Nervosa: the critical inner voices in eating disorders
05 / 10 / 2023
18:00 - 19:30
Lecture Hall C0.05
Science Park 904, University of Amsterdam FNWI
Many individuals diagnosed with eating disorders describe their disorder as being represented by an internal 'voice'. This voice has a powerful, negative and omnipotent nature that is associated with life-threatening eating disorder symptoms. Where do these harmful voices come from? Are they any different from critical self-talk in people without eating disorders? And most importantly - how can they be silenced?
In this special edition of BètaBreak, we will screen the short film “Nervosa” (13 min) and talk with two experts about the way group schema therapy could potentially be a viable treatment option. By doing so, we will not only discuss their research on eating disorders, but also give an insight into the lived-experience of an individual battling this mental illness.
How does schema therapy work? And how could Jade, the main character in “Nervosa”, use this method against her dysfunctional coping modes?
SPEAKERS:
Dr. Suzanne Mares is a senior researcher at GGNet Amarum, the expertise center for eating disorders in Zutphen and Nijmegen. Her primary areas of expertise include Anorexia, Post-Traumatic Stress Disorder (PTSD), and Bulimia. Alongside Dr. Roelofs (Riagg Maastricht), Dr. Mares has secured a 600,000 euro grant from ZonMw for a 5-year study. Their research will focus on evaluating the effectiveness and costs of group schema therapy for individuals with eating disorders across multiple treatment centers in the Netherlands. This study will involve a total of 232 patients from various institutions.
Dr. Jolijn Drost is a GZ-psychologist and senior schema therapist who works at Rivierduinen Eating Disorders Ursula in Leiden. She serves as a therapist in a group schema therapy program for individuals struggling with anorexia, bulimia, or Other Specified Feeding or Eating Disorder (OSFED). In addition to her role as a therapist, Drost also holds a teaching position at the RINO Group.
